SBIR/STTR Research Award

Durable hydrophilic coating to promote effective condom use

Award identifier 8b36279b4b5ffc0202b16bff7a21678824951d6d0b18e7efd366704ca136d327Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$904,574

Program and phase

SBIR · Phase II

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
HYDROGLYDE COATINGS, LLC
Proposal award date
2018-07-01
Contract end date
2020-06-30
UEI
UHE9MMCWBFM9
Solicitation number
PA17-302
Topic code
NICHD

Research abstract

The sexual health crisis associated with STI transmission is a $Billion economic burden in the American healthcare systemCenter of Disease ControlThere are aboutBillion unprotected sex acts withMillion new STI cases each year in the USThis epidemic is also a global problem with rising rates ofMillion new cases of STI transmission per year withMillion of these cases associated with HIVThe use of condoms is the best prevention method to minimize the spread of STIHowever the lack of adequate lubrication still remains to be a major universal drawback for consistent and correct condom useIn addition to increased risks for STI transmissioninadequately lubricious condoms result in mucosal microtraumapainincreased chances of condom breakageand decreased satisfaction between partnersThusthe HydroGlyde Coating was developed in response to the clear clinical and market need to improve condoms as the last significant technological improvements was more thanyears agoi eintroduction of silicone fluids as lubricantsThe HydroGlyde Coating is the first of its kind and represents a significant departure from all conventional latex condoms by eliminating the need for supplemental personal lubricants and offering longer lasting lubricityThe technological advantages includereduce mucosal microtrauma and frictional forces between the condom and tissue interfaceincrease correct condom usageimprove user satisfaction and pleasure for intercourseand importantlyan innovative solution to address health concerns of preventing the spread of STIs and unwanted pregnanciesThe successful completion of our Phase I validated the coating formulation to be scalable and that HydroGlyde condoms are fabricated with consistent reproducibility under GMP like conditions using our second generation coating prototypeHGCoatThe aims of our Phase II proposal aredevelopment and scale up of the HydroGlyde Coating formulation and execution of trial runs in a large scale condom manufacturing facility to produce HydroGlyde condoms under GMP standardsGPC Karexevaluation of the mechanical properties and biocompatibility of HydroGlyde condoms in accordance to ISOand ISOfor the preparation and filing of akfor FDA clearanceandperform an IRB approved marketing study with human subjects to obtain consumer feedback on HydroGlyde condomsCompletion of these studies will position us to gain FDA approval for HydroGlyde condomsexpand our HydroGlyde teamand initiate salesThe commercialization and introduction of this innovative condom coating technology to the market will offer a viable solution to address current health challenges by offering an improved condom product with superiordurable lubrication in order to promote correct and consistent usage Project Narrative The HydroGlyde Coating is a durable hydrophilic condom coating that maintains lubricity when the surface is wetted with water or aqueous solutionsThrough offering users with longer lasting condom lubricity without the need for additional personal lubricationsthis unique condom coating technology will promote consistent and proper condom usage which will reduce the spread of STIs and unwanted pregnanciesWith the successful completion of our Phase I SBIRwe will now complete the next milestones to commercialize HydroGlyde condoms by conducting GMP trial runs with our partner to produce HydroGlyde condomsperforming biocompatibility and mechanical ISO testingpreparing and filing akfor FDA clearance with the assistance of a regulatory teamand initiating an IRB approved marketing study for consumer feedback

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2016–2018). Reported award amounts total $1,105,175. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.